The roles of Toll-like receptors in atherosclerosis

Clett Erridge1

  • 1Department of Cardiovascular Sciences, Leicester University, Glenfield General Hospital, Leicester, UK. ce55@leicester.ac.uk

Insights

Toll-like receptors (TLRs) are key drivers in atherosclerosis, a chronic inflammatory arterial disease. This review highlights how TLR signaling promotes inflammatory responses and cholesterol dysregulation in macrophages, contributing to foam cell formation and disease progression.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Cell Biology

Background:

  • Atherosclerosis is a chronic inflammatory arterial disease.
  • Endothelial cell activation, monocyte recruitment, and macrophage foam cell formation characterize atherosclerosis.
  • Toll-like receptors (TLRs) initiate inflammatory signaling in response to microbial or damage-associated molecular patterns.

Purpose of the Study:

  • To review recent evidence implicating TLR-dependent signaling in vascular cell activation during atherogenesis.
  • To elucidate mechanisms by which TLR signaling promotes dysregulated macrophage cholesterol metabolism.
  • To identify potential TLR ligands relevant to atherogenesis and their exposure routes in vascular tissues.

Main Methods:

  • Review of recent experimental evidence and studies.
  • Analysis of TLR-dependent signaling pathways in vascular cells.
  • Investigation of macrophage cholesterol metabolism in the context of TLR activation.

Main Results:

  • TLRs play critical roles in the development of atherosclerosis.
  • TLR signaling activates vascular cells and promotes foam cell formation.
  • Mechanisms of TLR ligand identification and vascular exposure are explored.

Conclusions:

  • TLR-dependent signaling is integral to atherogenesis.
  • Targeting TLR pathways may offer therapeutic strategies for atherosclerosis.
  • Understanding TLR ligand-receptor interactions is crucial for managing arterial inflammation.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...